Cellerant Therapeutics Announces Timothy Fong as Vice President of...

Dr. Fong brings more than 20 years of drug development experience and has led research and development groups in cell and gene therapies, bio-active peptides and recombinant proteins from discovery research to early human clinical trials in oncology and autoimmune and inflammatory diseases.

http://ift.tt/1l46qGT